Functional evidence for the presence of tumor suppressor gene on chromosome 10p15 in human prostate cancers.

Abstract:

:Loss of heterozygosity on chromosome 10p was observed frequently in human prostate cancers. Studies have demonstrated that the introduction of the short arm of human chromosome 10 into a human prostate cancer cell line, PPC-1, by microcell-mediated chromosome transfer (MMCT), suppressed the malignant phenotype, suggesting the presence of a prostate tumor suppressor gene(s) within a region of 17 cM at distal 10p. To narrow down the candidate region harboring the tumor suppressor gene, a series of 10p fragments were transferred into PPC-1 cells by MMCT using a panel of hamster-human hybrid cells containing various portions of 10p. Four of the six hybrid cells obtained showed decreased tumorigenicity when injected subcutaneously into athymic nude mice. Tumors developed only at six of 40 injection sites for these four hybrid cells. In contrast, the other two hybrid cells, as well as parental PPC-1 cells, were judged to be fully tumorigenic because tumors appeared at a total 26 of 32 sites for the two hybrid cells and 15 of 16 sites for PPC-1. Allelotyping of 10p combined with fluorescence in situ hybridization in these hybrid cells suggested that a prostate tumor suppressor gene was located within a fragment of approximately 1.2 Mb flanked by D10S1172 and D10S226 on 10p15.1.

journal_name

Oncogene

journal_title

Oncogene

authors

Fukuhara H,Maruyama T,Nomura S,Oshimura M,Kitamura T,Sekiya T,Murakami Y

doi

10.1038/sj.onc.1204079

subject

Has Abstract

pub_date

2001-01-18 00:00:00

pages

314-9

issue

3

eissn

0950-9232

issn

1476-5594

journal_volume

20

pub_type

杂志文章

相关文献

ONCOGENE文献大全
  • The 'WS motif' common to v-mpl and members of the cytokine receptor superfamily is dispensable for myeloproliferative leukemia virus pathogenicity.

    abstract::Several motifs are conserved in the extracellular domain of the cloned chains of the recently described cytokine receptor superfamily. One of them, usually close to the transmembrane region, is the 'WS motif'. Its function remains unknown, but it has been recently shown that the integrity of this motif is essential fo...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Bénit L,Charon M,Cocault L,Wendling F,Gisselbrecht S

    更新日期:1993-03-01 00:00:00

  • Scribble acts as an oncogene in Eμ-myc-driven lymphoma.

    abstract::Scribble complex proteins maintain apicobasal polarity, regulate cell fate determination and function as tumour suppressors in epithelial tissue. Despite evidence that the function of Scribble is maintained in the lymphocyte lineage, we still understand little about its role as a tumour suppressor in haematological ma...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2015.167

    authors: Hawkins ED,Oliaro J,Ramsbottom KM,Newbold A,Humbert PO,Johnstone RW,Russell SM

    更新日期:2016-03-03 00:00:00

  • New insights into apoptosis signaling by Apo2L/TRAIL.

    abstract::Apoptosis ligand 2 tumor necrosis factor (TNF)-related apoptosis-inducing ligand (Apo2L/TRAIL) belongs to a small subset of proapoptotic protein ligands in the TNF superfamily. This subset, which also includes Fas ligand and TNF-alpha, can activate the extrinsic apoptotic cell death pathway on binding to cognate death...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2010.221

    authors: Gonzalvez F,Ashkenazi A

    更新日期:2010-08-26 00:00:00

  • Overexpression of Aurora-A potentiates HRAS-mediated oncogenic transformation and is implicated in oral carcinogenesis.

    abstract::Aurora kinases are known to play a key role in maintaining mitotic fidelity, and overexpression of aurora kinases has been noted in various tumors. Overexpression of aurora kinase activity is thought to promote cancer development through a loss of centrosome or chromosome number integrity. Here we observed augmentatio...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208293

    authors: Tatsuka M,Sato S,Kitajima S,Suto S,Kawai H,Miyauchi M,Ogawa I,Maeda M,Ota T,Takata T

    更新日期:2005-02-03 00:00:00

  • NF-kappa B precursor p100 inhibits nuclear translocation and DNA binding of NF-kappa B/rel-factors.

    abstract::The NF-kappa B precursor p100 (lyt-10, p97, p98) generates after proteolytic processing a 52 kDa subunit, which can bind to kappa B-motifs. A deregulated form of the p100 gene, which is structurally altered by a t(10;14) translocation, has a potential oncogenic role in certain human B cell lymphomas. In this study p10...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Naumann M,Nieters A,Hatada EN,Scheidereit C

    更新日期:1993-08-01 00:00:00

  • MHC class I dysfunction of glioma stem cells escapes from CTL-mediated immune response via activation of Wnt/β-catenin signaling pathway.

    abstract::Glioma stem cells (GSCs) decrease T cells cognition and evade systemic immunosurveillance via downregulations or defects of major histocompatibility complex class I (MHC-I) molecule and antigen-processing machinery (APM) components. Improvement of tumor surface antigens of GSCs may be effective strategy to trigger an ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-019-1045-6

    authors: Yang W,Li Y,Gao R,Xiu Z,Sun T

    更新日期:2020-01-01 00:00:00

  • Interactions of the DNA mismatch repair proteins MLH1 and MSH2 with c-MYC and MAX.

    abstract::MSH2 and MLH1 have a central role in correcting mismatches in DNA occurring during DNA replication and have been implicated in the engagement of apoptosis induced by a number of cytotoxic anticancer agents. The function of MLH1 is not clearly defined, although it is required for mismatch repair (MMR) and engagement of...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206252

    authors: Mac Partlin M,Homer E,Robinson H,McCormick CJ,Crouch DH,Durant ST,Matheson EC,Hall AG,Gillespie DA,Brown R

    更新日期:2003-02-13 00:00:00

  • The induction and activation of STAT1 by all-trans-retinoic acid are mediated by RAR beta signaling pathways in breast cancer cells.

    abstract::Retinoic acid receptor-beta (RAR beta) and signal transducer and activator of transcription 1 (STAT1) are important mediators of the antiproliferative and apoptotic actions of retinoids and cytokines/growth factors, respectively. Expression of both RAR beta and STAT1 is lost in most breast cancer cell lines but it can...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203084

    authors: Shang Y,Baumrucker CR,Green MH

    更新日期:1999-11-18 00:00:00

  • Targeted expression of c-Myc in the epidermis alters normal proliferation, differentiation and UV-B induced apoptosis.

    abstract::c-Myc overexpression has been associated with several types of human cancers. To study the role of c-myc in epidermal differentiation and carcinogenesis, a transgenic mouse model was created to overexpress c-Myc in the epidermis. Human c-myc 2 cDNA was subcloned into a 6.5 kb mouse loricrin expression vector, ML.myc2....

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203040

    authors: Waikel RL,Wang XJ,Roop DR

    更新日期:1999-08-26 00:00:00

  • To replicate or not to replicate: achieving selective oncolytic virus replication in cancer cells through translational control.

    abstract::To ensure that their mRNAs are translated and that the viral proteins necessary for assembling the next generation of infectious progeny are produced, viruses must effectively seize control of the translational machinery within their host cells. In many cases, the ability to productively engage host translational comp...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1209053

    authors: Mohr I

    更新日期:2005-11-21 00:00:00

  • Direct interaction of Gadd45 with PCNA and evidence for competitive interaction of Gadd45 and p21Waf1/Cip1 with PCNA.

    abstract::We have previously shown (Smith et al., 1994) that antibodies raised against the growth arrest and DNA damage inducible protein Gadd45 co-precipitate proliferating cell nuclear antigen (PCNA), a protein involved in DNA replication and repair. Here we demonstrate that Gadd45 can directly bind to PCNA using a Far-wester...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Chen IT,Smith ML,O'Connor PM,Fornace AJ Jr

    更新日期:1995-11-16 00:00:00

  • The EGF receptor family as targets for cancer therapy.

    abstract::Human carcinomas frequently express high levels of receptors in the EGF receptor family, and overexpression of at least two of these receptors, the EGF receptor (EGFr) and closely related ErbB2, has been associated with a more aggressive clinical behavior. Further, transfection or activation of high levels of these tw...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1204082

    authors: Mendelsohn J,Baselga J

    更新日期:2000-12-27 00:00:00

  • Overexpression of c-fos in a human pre-B cell acute lymphocytic leukemia derived cell line, SMS-SB.

    abstract::The c-fos proto-oncogene is found to be overexpressed at least 30-fold in SMS-SB, a pre-B leukemic cell line compared to other cell types. No gross alteration of the c-fos gene structure in SMS-SB cells can be detected by karyotypic or Southern analyses. C-fos in SMS-SB cells can still be induced by serum, TPA and the...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Tsai LH,Nanu L,Smith RG,Ozanne B

    更新日期:1991-01-01 00:00:00

  • Cancer stem cell self-renewal as a therapeutic target in human oral cancer.

    abstract::Tumor recurrence following treatment remains a major clinical challenge in oral cavity cancer. Cancer stem cells (CSCs) have been isolated from human oral cancers and been considered as the driving force of tumor recurrence and metastasis. However, it still remains unclear whether targeting CSCs in oral cancer is a cl...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-019-0800-z

    authors: Hu J,Mirshahidi S,Simental A,Lee SC,De Andrade Filho PA,Peterson NR,Duerksen-Hughes P,Yuan X

    更新日期:2019-07-01 00:00:00

  • Mammary epithelial-specific expression of the integrin-linked kinase (ILK) results in the induction of mammary gland hyperplasias and tumors in transgenic mice.

    abstract::The integrin linked kinase (ILK) is a cytoplasmic effector of integrin receptors, involved in the regulation of integrin binding properties as well as the activation of cell survival and proliferative pathways, including those involving MAP kinase, PKB/Akt and GSK-3beta. Overexpression of ILK in cultured intestinal an...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204910

    authors: White DE,Cardiff RD,Dedhar S,Muller WJ

    更新日期:2001-10-25 00:00:00

  • Actin cytoskeleton polymerization in Dbl-transformed NIH3T3 fibroblasts is dependent on cell adhesion to specific extracellular matrix proteins.

    abstract::The Dbl oncogene is the putative exchange factor for two small GTP-binding proteins, RhoA and CDC42 which are involved in the polymerization of actin to produce stress fibers and filopodia, respectively. We report here that Dbl oncogene-transformed NIH3T3 cells show actin stress fibers only when cells are plated on fi...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201027

    authors: Defilippi P,Olivo C,Tarone G,Mancini P,Torrisi MR,Eva A

    更新日期:1997-04-24 00:00:00

  • Chk1 complements the G2/M checkpoint defect and radiosensitivity of ataxia-telangiectasia cells.

    abstract::Cells from patients with the human genetic disorder ataxia-telangiectasia (A-T) are defective in the activation of cell cycle checkpoints in response to ionizing radiation damage. In order to understand the role of ATM in checkpoint control we investigated whether Schizosaccaromyces pombe chk1, a protein kinase implic...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202257

    authors: Chen P,Gatei M,O'Connell MJ,Khanna KK,Bugg SJ,Hogg A,Scott SP,Hobson K,Lavin MF

    更新日期:1999-01-07 00:00:00

  • Rel/NF-kappa B transcription factors and I kappa B inhibitors: evolution from a unique common ancestor.

    abstract::From the sequences of Rel/NF-kappa B and I kappa B proteins, we constructed an alignment of their Rel Homology Domain (RHD) and ankyrin repeat domain. Using this alignment, we performed tree reconstruction with both distance matrix and parsimony analysis and estimated the branching robustness using bootstrap resamplin...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201471

    authors: Huguet C,Crepieux P,Laudet V

    更新日期:1997-12-11 00:00:00

  • Developmental regulation of intermediate filament and actin mRNAs during myogenesis is disrupted by oncogenic ras genes.

    abstract::Terminal differentiation of skeletal myoblasts is accompanied by down-regulation of vimentin and beta-, gamma-actins and up-regulation of desmin and sarcomeric alpha-actin(s). To investigate whether the normal decline in expression of vimentin and beta-, gamma-actins was coupled to withdrawal of proliferating myoblast...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Olson EN,Capetanaki YG

    更新日期:1989-07-01 00:00:00

  • Poly(ADP-ribosyl)ation of p53 induces gene-specific transcriptional repression of MTA1.

    abstract::The metastasis-associated protein 1 (MTA1) is overexpressed in various human cancers and is closely connected with aggressive phenotypes; however, little is known about the transcriptional regulation of the MTA1 gene. This study identified the MTA1 gene as a target of p53-mediated transrepression. The MTA1 promoter co...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.2

    authors: Lee MH,Na H,Kim EJ,Lee HW,Lee MO

    更新日期:2012-12-06 00:00:00

  • Oncogenic activation of c-Abl in non-small cell lung cancer cells lacking FUS1 expression: inhibition of c-Abl by the tumor suppressor gene product Fus1.

    abstract::In lung cancer, frequent loss of one allele of chromosome 3p is seen in both small cell lung cancer and non-small cell lung cancer (NSCLC), providing evidence of tumor suppressor genes (TSGs) in this chromosomal region. The mechanism of Fus1 tumor suppressor activity is unknown. We have found that a Fus1 peptide inhib...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210500

    authors: Lin J,Sun T,Ji L,Deng W,Roth J,Minna J,Arlinghaus R

    更新日期:2007-10-25 00:00:00

  • ApoC1 promotes the metastasis of clear cell renal cell carcinoma via activation of STAT3.

    abstract::Clear cell renal cell carcinoma (ccRCC) is the most common renal cancer and frequently diagnosed at an advanced stage. It is prone to develop unpredictable metastases even with proper treatment. Antiangiogenic therapy is the most effective medical treatment for metastatic ccRCC. Thus, exploration of novel approaches t...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-020-01428-3

    authors: Li YL,Wu LW,Zeng LH,Zhang ZY,Wang W,Zhang C,Lin NM

    更新日期:2020-09-01 00:00:00

  • Suppression of v-Src transformation in primary rat embryo fibroblasts.

    abstract::To understand the mechanism for resistance of primary cultures of rat embryo fibroblasts (REFs) to oncogene-induced transformation, we studied the transforming ability of a recombinant retrovirus, ZSV, containing v-src and neo genes in REFs and in the rat cell line F2408. The susceptibility of REFs to p60v-src transfo...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Inoue H,Tavoloni N,Hanafusa H

    更新日期:1995-07-20 00:00:00

  • Serum induction of the fibroblast growth factor-binding protein (FGF-BP) is mediated through ERK and p38 MAP kinase activation and C/EBP-regulated transcription.

    abstract::The fibroblast growth factor-binding protein (FGF-BP) modulates FGF activity through binding and release from the extracellular matrix. Consequently, the expression of FGF-BP in certain tumor types is a rate-limiting regulator of FGF-mediated angiogenesis. FGF-BP is upregulated in squamous cell carcinoma by treatment ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204249

    authors: Harris VK,Kagan BL,Ray R,Coticchia CM,Liaudet-Coopman ED,Wellstein A,Tate Riegel A

    更新日期:2001-03-29 00:00:00

  • siRNA screening identifies differences in the Fanconi anemia pathway in BALB/c-Trp53+/- with susceptibility versus C57BL/6-Trp53+/- mice with resistance to mammary tumors.

    abstract::BALB/c mice heterozygous for Trp53 develop a high proportion of spontaneous mammary tumors, a phenotype distinct from other mouse strains. BALB/c-Trp53+/- female mice, thus, resemble the hereditary Li-Fraumeni syndrome (LFS) characterized by early-onset of breast cancer, even though LFS involves TP53 mutations, which ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2013.38

    authors: Böhringer M,Obermeier K,Griner N,Waldraff D,Dickinson E,Eirich K,Schindler D,Hagen M,Jerry DJ,Wiesmüller L

    更新日期:2013-11-28 00:00:00

  • Akt regulates nuclear/cytoplasmic localization of tuberin.

    abstract::The autosomal dominantly inherited disease tuberous sclerosis (TSC) affects approximately 1 in 6000 individuals and is characterized by the development of tumors, named hamartomas, in different organs. TSC1, encoding hamartin, and TSC2, encoding tuberin are tumor suppressor genes responsible for TSC. Hamartin and tube...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209812

    authors: Rosner M,Freilinger A,Hengstschläger M

    更新日期:2007-01-25 00:00:00

  • Significance of PELP1/HDAC2/miR-200 regulatory network in EMT and metastasis of breast cancer.

    abstract::Tumor metastasis is the leading cause of death among breast cancer patients. PELP1 (proline, glutamic acid and leucine rich protein 1) is a nuclear receptor coregulator that is upregulated during breast cancer progression to metastasis and is an independent prognostic predictor of shorter survival of breast cancer pat...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2013.332

    authors: Roy SS,Gonugunta VK,Bandyopadhyay A,Rao MK,Goodall GJ,Sun LZ,Tekmal RR,Vadlamudi RK

    更新日期:2014-07-10 00:00:00

  • The t(2;3)(q21;q27) translocation in non-Hodgkin's lymphoma displays BCL6 mutations in the 5' regulatory region and chromosomal breakpoints distant from the gene.

    abstract::The BCL6 gene, mapped at the chromosomal band 3q27, encodes a POZ/Zinc finger transcription repressor protein. It is frequently activated in Non-Hodgkin's lymphomas (NHL) by translocations with breakpoints clustering in the 5' major breakpoint region (MBR) as well as by mutations in the same region. The translocations...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202098

    authors: Chen W,Butler M,Rao PH,Chaganti SR,Louie DC,Dalla-Favera R,Chaganti RS

    更新日期:1998-10-01 00:00:00

  • TRIM24 links glucose metabolism with transformation of human mammary epithelial cells.

    abstract::Tripartite motif 24 protein (TRIM24) is a plant homeodomain/bromodomain histone reader, recently associated with poor overall survival of breast-cancer patients. At a molecular level, TRIM24 is a negative regulator of p53 levels and a co-activator of estrogen receptor. However, the role of TRIM24 in breast tumorigenes...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2014.220

    authors: Pathiraja TN,Thakkar KN,Jiang S,Stratton S,Liu Z,Gagea M,Shi X,Shah PK,Phan L,Lee MH,Andersen J,Stampfer M,Barton MC

    更新日期:2015-05-28 00:00:00

  • Nucleocytoplasmic transport of HTLV-1 RNA is regulated by two independent LTR encoded nuclear retention elements.

    abstract::Appropriate expression of HTLV-1 genes requires transcriptional transactivation by Tax and post-transcriptional regulation by Rex, both mediated by LTR encoded RNA sequences. Using a combination of deletion mutagenesis, Rex-reporter CAT assays, fluorescence in situ hybridization (FISH) and confocal laser scanning micr...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201884

    authors: King JA,Bridger JM,Löchelt M,Lichter P,Schulz TF,Schirrmacher V,Khazaie K

    更新日期:1998-06-25 00:00:00